Cargando…

Factors predicting recurrent endometrial cancer

Objectives: The aim of this study was to identify (prognostic) factors that may predict the development of recurrent endometrial cancer and may improve the choice of adjuvant therapy subsequently. Methods: Data of all patients, diagnosed with primary endometrial cancer in Orbis Medical Center Sittar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huijgens, A.N.J., Mertens, H.J.M.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Universa Press 2013
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987371/ https://www.ncbi.nlm.nih.gov/pubmed/24753943

Ejemplares similares

Implementation of laparoscopic surgery for endometrial cancer: work in progress
por: Van den Bosch, AAS, et al.
Publicado: (2016)

Improving external cephalic version for foetal breech presentation
por: Zandstra, H., et al.
Publicado: (2013)

Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer
por: Eriksson, L. S. E., et al.
Publicado: (2021)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

Histopathological Prognostic Factors for Endometrial Carcinoma
por: FLORESCU, M.M., et al.
Publicado: (2016)

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
por: Vogel, Rachel Isaksson, et al.
Publicado: (2016)

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters
por: Versluis, M A, et al.
Publicado: (2015)

Recurrence risk factors in stage IA grade 1 endometrial cancer
por: Nwachukwu, Chika, et al.
Publicado: (2021)

Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
por: Kang, Seo Young, et al.
Publicado: (2017)

Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins
por: Kulkarni, A., et al.
Publicado: (2023)

A predictive model based on site-specific risk factors of recurrence regions in endometrial cancer patients
por: Shin, Wonkyo, et al.
Publicado: (2022)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2022)

Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers
por: Jiang, Peng, et al.
Publicado: (2020)

Serial endometrial thickness and risk of non‐endometrial hormone‐dependent cancers in postmenopausal women in UK Collaborative Trial of Ovarian Cancer Screening
por: Burnell, M., et al.
Publicado: (2020)

Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy
por: Ren, Kang, et al.
Publicado: (2022)

The role of angiogenic factors in endometrial cancer
por: Żyła, Monika Magdalena, et al.
Publicado: (2014)

Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations
por: Walker, Christopher J., et al.
Publicado: (2017)

Multivariate survival analysis of the patients with recurrent endometrial cancer
por: Odagiri, Tetsuji, et al.
Publicado: (2011)

Evaluation of peripheral nodal recurrence in patients with endometrial cancer
por: Kılıç, Fatih, et al.
Publicado: (2022)

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer
por: Berg, Anna, et al.
Publicado: (2016)

Endometrial histopathology results and evaluation of endometrial cancer risk in geriatric women
por: Günakan, Emre, et al.
Publicado: (2018)

HISTOPATHOLOGIC PARAMETERS OF POSITIVE LYMPH NODE PREDICTABILITY IN ENDOMETRIAL CANCER
por: Mandić, Aljoša, et al.
Publicado: (2022)

Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors
por: Merritt, Melissa A., et al.
Publicado: (2016)

CD4+ and CD8+ preimplantation endometrial population in women with unexplained recurrent miscarriage
por: Abdelrahim, Ahmed, et al.
Publicado: (2023)

Prediction of lymphovascular space invasion in patients with endometrial cancer
por: Kim, Sang Il, et al.
Publicado: (2021)

Endometrial Cancer Patients: A Cohort Previous to Changes in Tumour Behaviour and Treatment Strategies
por: Tournois, F. K. L., et al.
Publicado: (2011)

The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020)

Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer
por: Sekii, Shuhei, et al.
Publicado: (2017)

Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021)

Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages
por: Rahman, Tanzil Ur, et al.
Publicado: (2018)

An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF
por: Koot, Yvonne E. M., et al.
Publicado: (2016)

The application of machine learning for predicting recurrence in patients with early-stage endometrial cancer: a pilot study
por: Akazawa, Munetoshi, et al.
Publicado: (2021)

Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
por: Li, Ning, et al.
Publicado: (2022)

Correlation of Metabolic Factors with Endometrial Atypical Hyperplasia and Endometrial Cancer: Development and Assessment of a New Predictive Nomogram
por: Zhang, He, et al.
Publicado: (2021)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

New therapies for advanced, recurrent, and metastatic endometrial cancers
por: Makker, Vicky, et al.
Publicado: (2017)

Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020)

Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome
por: Park, Joon Cheol, et al.
Publicado: (2011)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
por: Takahashi, Kenta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8fqvh0ibot5kg4h0v5dticvu05